Borghaei, H., Langer, C.J., Paz-Ares, L., Rodrı ´guez-Abreu, D., Halmos, B., Garassino, M.C., Houghton, B., Kurata, T., Cheng, Y., Lin, J., et al. (2020).Pembrolizumab plus chemotherapy versus chemotherapy alone in patientswith advanced non-small cell lung cancer without tumor PD-L1 expression:a pooled analysis of 3 randomized controlled trials. Cancer 126, 4867–4877.